Evaluation of Early Subclinical Cardiotoxicity of Chemotherapy in Breast Cancer

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
doi 10.5152/akd.2014.5185
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Kare Publishing

Related search

Subclinical Cardiotoxicity Following Adjuvant Dose-Escalated FEC, High-Dose Chemotherapy, or CMF in Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2000English

Trastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study

Oncologist
Cancer ResearchMedicineOncology
2013English

Adjuvant Chemotherapy for Early Breast Cancer.

BMJ
1983English

Neoadjuvant Chemotherapy for Early Breast Cancer – Author's Reply

The Lancet Oncology
Oncology
2018English

Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2015English

Neoadjuvant Chemotherapy in Breast Cancer

English

The Predictive Value of the 70-Gene Signature for Adjuvant Chemotherapy in Early Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Metronomic Chemotherapy in Metastatic Breast Cancer

Novel Research in Sciences
2019English

Neoadjuvant Chemotherapy: Role in Breast Cancer

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy